Krystal Biotech Inc Cash Flow Reinvestment Rate
Krystal Biotech Inc cash flow reinvestment rate. Krystal Biotech Inc (KRYS) has a Cash Flow Reinvestment Rate of 2.16x as of June 2026, reinvesting $161.58 Million (capex $3.56 Million plus investments $-158.02 Million) from operating cash flow of $74.79 Million. Explore KRYS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Krystal Biotech Inc (2024–2025)
Cash flow reinvestment rate of Krystal Biotech Inc from 2024 to 2025. Historical reinvestment intensity for Krystal Biotech Inc across 2 annual periods. Explore KRYS capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Krystal Biotech Inc Cash Flow Reinvestment Rate by Year (2024–2025)
Krystal Biotech Inc cash flow reinvestment rate by year from 2024 to 2025. Year-by-year capital reinvestment analysis for Krystal Biotech Inc. For the full cash flow conversion analysis, see Krystal Biotech Inc (KRYS) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $58.85 Million | $200.87 Million | $11.95 Million | ▼ -78.4% |
| 2024 | 1.36x | $167.68 Million | $123.42 Million | $4.24 Million | — |